Zoetis Services LLC.

Company Snapshot

Founded: 2013
Entity Type: Public
Employees: 4,050
Region: U.S.
Revenue: $9,256.0 Millions
Revenue Year: 2024
Headquarter: New Jersey, U.S.
Key Geographics: U.S., International
Corporate Address: 10 Sylvan Way, Parsippany, New Jersey 07054 U.S. Tel. +1-973-822-7000 www.zoetis.com

Company Overview

Zoetis Inc. is a global leader in the animal health industry, focusing on developing, discovering, manufacturing, and commercializing medicines and vaccines for farmers. The company has diverse business products across species including dogs, cats, equine, livestock, swine, poultry, and fish. The company’s origins go back 70 years; it has a focus on innovating different ways of predicting and preventing animal diseases. Zoetis has approximately 300 product lines sold over 100 countries for the prediction, prevention, detection, and treatment of diseases. In 2013, Pfizer split off its Animal Health business, launching one of the largest animal health companies worldwide, Zoetis Inc. It announced in 2011 that it was seeking potential alternative options for the business, and one of the options was a company split. As an independent company, Zoetis currently focuses on the discovery, development, manufacturing, and marketing of vaccines, medicines, and diagnostics for animals.

Financial Highlights (FY 2024)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

Zoetis Services LLC. In Reports

Global Markets for Animal Therapeutics and Diagnostics

BCC Research Market Report says global market for animal therapeutics and diagnostics is estimated to increase from $61.0 billion in 2023 to reach $81.2 billion by 2028, at a CAGR of 5.9%.

Veterinary Vaccines: Global Markets

According to BCC Research Report The global veterinary vaccines market reached $9.1 billion in 2022 should reach $9.6 billion by 2023 and $14.2 billion by 2028 with a CAGR of 8.2%.

Point of Care Diagnostics: Technologies and Global Markets

BCC Research Market Report for point of care diagnosis should grow from $24.8 billion in 2021 to $43.5 billion by 2026 with a compound annual growth rate (CAGR) of 11.9%

Company's Business Segments

  • Companion Animal : Vaccines and Medicines for Dogs and Cats, Horses.
  • Livestock : Vaccines and Medicines for Cattle, Poultry, Swine, Fish, Sheep and Others.

Applications/End User Industries

  • Parasiticides
  • Vaccines
  • Dermatology
  • Anti Infectives
  • Pain and Sedation
  • Animal Health Diagnostics
  • Medicated Feed Additives
AI Sentiment